Illustration of a clinic building (not a photo of Northern Vascular Lab)
Illustration

Mark S. Morginstin, MD

Hematology/oncology in Philadelphia, PA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 30 years since graduation
  • Public record — not managed by the clinician

About Dr. Mark Morginstin

Dr. Mark Morginstin is a physician specializing in hematology/oncology practicing in Philadelphia, PA, a graduate of Rowan University School of Osteopathic Medicine (1996). Affiliated with Jefferson Einstein Montgomery Hospital, Jefferson Einstein Philadelphia Hospital, Jefferson Lansdale Hospital. Treated 409 Medicare patients in 2024.

Provider details

SpecialtyHematology/oncologyOther hematology/oncology doctors in Philadelphia
CredentialsMD
EducationRowan University School of Osteopathic Medicine, 1996CMS Doctors and Clinicians
GenderMale
NPI number1124000278National Provider Identifier (CMS NPPES), issued November 2005
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Mark Morginstin's specialties and state licenses

  • Hematology & Oncology Primary
    License: PA OS011961
  • Internal Medicine
    License: CT 042818

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Mark Morginstin practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Mark Morginstin

  • Jefferson Einstein Montgomery HospitalHospital · East Norriton, PA
  • Jefferson Einstein Philadelphia HospitalHospital · Philadelphia, PA
  • Jefferson Lansdale HospitalHospital · Lansdale, PA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mark Morginstin's Medicare patients and services (2024)

409Medicare patients
961services billed
76average patient age
52%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more503$102.74
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more265$152.41
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes75$138
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes57$125.32
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more52$192.49

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis51%
  • Ischemic heart disease48%
  • Cancer44%
  • Chronic kidney disease39%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Mark Morginstin (2025)

$441.15 in 12 general payments reported in 2025.

TypePaymentsAmount
Food and beverage9$247.67
Education3$193.48

Paying companies: Sobi, Inc ($170.98), AstraZeneca Pharmaceuticals LP ($107.50), Daiichi Sankyo Inc. ($52.34), EISAI INC. ($33.57), NOVARTIS PHARMACEUTICALS CORPORATION ($31.33), Bayer HealthCare Pharmaceuticals Inc. ($25.79).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Northern Vascular Lab

Questions about Dr. Mark Morginstin

What kind of clinician is Dr. Mark Morginstin?

Dr. Mark Morginstin is listed as a physician specializing in hematology/oncology.

Where does Dr. Mark Morginstin practice?

Northern Vascular Lab at 5501 Old York Rd, Suite 3, Philadelphia, PA 19141.

What is the office phone number for Dr. Mark Morginstin?

The listed office number is (215) 456-3880. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Mark Morginstin?

The National Provider Identifier is 1124000278.

Does Dr. Mark Morginstin accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mark Morginstin affiliated with?

Jefferson Einstein Montgomery Hospital, Jefferson Einstein Philadelphia Hospital, Jefferson Lansdale Hospital.

Where did Dr. Mark Morginstin go to medical school?

Rowan University School of Osteopathic Medicine, graduating in 1996.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2011-06-20
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call Northern Vascular Lab at (215) 456-3880 or visit the clinic page to check availability.

Call now
0 clinics selected Compare